Market news

Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Bills in the U.S. and U.K. seek to ban superintelligent AI, as fears grow about increasingly powerful systems escaping human control.

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The rogue OpenAI agents that attacked Hugging Face suggest an AI escape could be on the horizon. To understand the risks, consider invasive species.

Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Spirit Airlines deal points to AI companies’ growing ambitions to automate white-collar work.

Perrigo makes private-label over-the-counter drugs, which sounds like a reliable business, but there are warning signs to consider before you buy it.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Demis Hassabis' move to a new Google role is part of a broader DeepMind reorganization, according to people familiar with the changes, as leadership shifts and teams are restructured.

PRGO tops Q2 EPS estimates as Infant Formula sales jump, helping offset softer demand and divestiture impacts while the company reaffirms 2026 guidance.

Moby summary of Perrigo Company plc's Q2 2026 earnings call

Perrigo Co PLC (PRGO) navigates a challenging quarter with strategic wins in infant formula and innovation, despite a 3.1% core net sales dip.